Carregant...
Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs
[Image: see text] Although tyrosine kinase inhibitors (TKIs) have revolutionized cancer therapy in the past two decades, severe drawbacks such as strong adverse effects and drug resistance limit their clinical application. Prodrugs represent a valuable approach to overcoming these disadvantages by a...
Guardat en:
| Publicat a: | Inorg Chem |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American
Chemical Society
2020
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724630/ https://ncbi.nlm.nih.gov/pubmed/33222438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.inorgchem.0c03083 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|